Utilizamos cookies para personalizar el contenido y publicidad, proporcionar funciones de redes sociales y analizar nuestro tráfico. Para obtener más información consulta nuestra política de cookies.

EquitiesBuy DHR Stock

Comprar Danaher

DHR

loading

What is DHR?

Founded in 1969, Washington, D.C.-based Danaher Corporation is a globally diversified healthcare conglomerate. It’s best-known as a manufacturer of medical devices.

As of December 2020, Danaher had a market capitalization of $166 billion.

In March 2020, the company acquired the GE Biopharma business and renamed it Cytiva. During the ambitious, complicated vaccine roll outs in the coming months, Cytiva will be called upon to do its part. Indeed, the U.S. government has entered an agreement with the Danaher division to expand the manufacturing of products needed to make COVID-19 vaccines.

Danaher is viewed as having healthy growth opportunities, owing to the coming role in the vaccination mission but generally due to robust fundamentals and an improving operating environment. If anything, Danaher is diversified. Just look at Danaher's Life Sciences segment. This business line alone provides: mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; genomics consumables; filtration, separation, and purification technologies.

What is the price of DHR? 

At roughly $226 per share (as of December 2020), DHR is up 47% since the start of the year. It’s been as high as $250 and as low as $120 over the past 12 months. Heading into 2021, DHR stock is roughly 140% higher than it was at the beginning of 2018.

Currently, Wall Street’s consensus estimate for earnings in 2021 is pegged at $6.99, an increase of 10%. Danaher’s P/E is up to about 53x, compared to 27x in 2018.

Danaher believes in rewarding shareholders through dividend payments. In the first nine months of 2020, the company distributed dividends totaling $445.4 million to its shareholders, reflecting an increase of 15.7%.

In third-quarter 2020, according to Zacks, Danaher’s earnings and sales surpassed estimates by 25.5% and 6.6%, respectively. Zacks rates it as a buy opportunity.

How to buy DHR

With Uphold, you can buy equities in just 11 clicks - even if you don’t have an account yet. 

Nothing could be easier.

Here’s how fast it is to get started:

1. Go to Uphold.com and click sign up.

2. Enter your email address and personal details. 

3. Click the link we send you and create a password

… and you’re off to the races!

Just start trading.

Open an Uphold account

*U.S. stock trading is not available in the U.S., U.K., and certain other jurisdictions.

This article is for informational purposes only and takes no account of particular personal or market circumstances, and should not be relied upon as investment, tax, or legal advice. For investment, tax, or legal advice, and before taking any action you should consult your own advisors. Note that assets such as equities present unique risks for investors.

This content is correct as of December 2020

Get more coin for your coin

0% deposit fees 0% withdrawal fees

Learn more